Gilead Sciences GILD Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 315.4%+1.1pp | 314.4%+0.6pp | 313.8%+2.6pp | 311.2%+2.8pp | 308.4%+2.5pp | |
| Operating margin | 132.9%+6.3pp | 126.6%+28.3pp | 98.3%+33.2pp | 65.2%+18.7pp | 46.5%+22.9pp | |
| Net margin | 109.6%+10.2pp | 99.4%+27.2pp | 72.2%+27.4pp | 44.7%+18.1pp | 26.7%+19.0pp | |
| Returns | ||||||
| Return on equity | 157.5%+10.7pp | 146.8%+38.2pp | 108.6%+39.9pp | 68.7%+27.9pp | 40.7%+30.0pp | |
| Return on invested capital | 86.7%+4.4pp | 82.3%+19.3pp | 63%+21.3pp | 41.6%+13.7pp | 27.9%+17.4pp | |
| Efficiency | ||||||
| Asset turnover | 2.1×0.0× | 2.1×0.0× | 2×0.0× | 2×0.0× | 1.9×0.0× | |
| Liquidity | ||||||
| Current ratio | 6.3×+0.6× | 5.7×0.0× | 5.7×+0.2× | 5.5×+0.2× | 5.4×+0.3× | |
| Leverage | ||||||
| Debt-to-equity | 4.5×-0.4× | 4.9×-0.3× | 5.1×-0.1× | 5.2×0.0× | 5.3×-0.1× | |
| Net debt / EBITDA | 7.1×-0.6× | 7.7×-6.8× | 14.4×-13.6× | 28×-3.5× | 31.5×-4.6× | |
| Per Share | ||||||
| Book value per share | $69.70+5.3% | $66.16+4.2% | $63.48+4.0% | $61.03+1.8% | $59.97+2.0% | |
| Valuation | ||||||
| Market capitalization | $596.35B+5.9% | $563.05B+7.1% | $525.88B+6.8% | $492.53B+10.8% | $444.66B+12.2% | |
| Price / earnings | 74.8×-4.6× | 79.4×-222× | 301.4×-811× | 1,112.8×-60.0× | 1,172.8×-165× | |
| Price / sales | 20.3×+1.0× | 19.4×+1.2× | 18.2×+1.0× | 17.2×+1.5× | 15.6×+1.5× | |
| Price / book | 27.2×+0.1× | 27.2×+0.8× | 26.4×+0.7× | 25.7×+2.1× | 23.6×+2.1× | |
| EV / EBITDA | 66.3×-0.7× | 67.1×-48.4× | 115.5×-87.9× | 203.5×-11.9× | 215.4×-17.5× | |
| Dividend yield | 10.8%-0.5pp | 11.3%-0.8pp | 12.1%-0.8pp | 12.9%-1.5pp | 14.5%-1.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Gilead Sciences's profit margins?
- Gilead Sciences (GILD) runs a 79.4% gross margin and a 34.9% operating margin, with a 31.0% net margin.
- Where do Gilead Sciences's ratios come from?
- Every ratio is computed from Gilead Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
